MétaCan
Menu
Back to cohort
Record W4229046517 · doi:10.1055/s-0042-1746068

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE

2022· article· en· W4229046517 on OpenAlexaff
Ralf Eschbach, Monika Hofmann, L Späth, Lena M. Unterrainer, Andreas Delker, Stephan H. Lindner, Carmen Wängler, B. Wängler, Ralf Schirrmacher, Reinhold Tiling, Matthias Brendel, Andrei Todica, Harun Ilhan, Vera Wenter, Franziska J. Dekorsy, Freba Grawe, Johannes Rübenthaler, CC Cyran, Ch. Spitzweg, C.J. Auernhammer, Peter Bartenstein, Leonie Beyer

Bibliographic record

VenueNuklearmedizin - NuclearMedicine · 2022
Typearticle
Languageen
FieldMedicine
TopicNeuroendocrine Tumor Research Advances
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsSomatostatin receptorSomatostatinPositron emission tomographyNeuroendocrine tumorsSomatostatin receptor 2Somatostatin AnalogueNeuroendocrine tumourMedicineSomatostatin receptor 1Receptor expressionReceptorInternal medicineOctreotideNuclear medicineEndocrinologyCancer research

Abstract

fetched live from OpenAlex

Ziel/Aim Somatostatin analogues (SSA) are frequently used in the treatment of neuroendocrine tumours. With 18 F-SiTATE recently entering the field of somatostatin receptor (SSTR) positron emission tomography (PET)/ computed tomography (CT) imaging, the purpose of this study was to compare the SSTR-expression of differentiated gastroentero-pancreatic neuroendocrine tumours (GEP-NET) measured by 18 F-SiTATE-PET/CT in patients with and without previous treatment with long-acting SSAs to evaluate if SSA treatment needs to be paused prior to 18 F-SiTATE-PET/CT. Methodik/Methods 76 patients were examined with standardized 18 F-SiTATE-PET/CT within clinical routine: 39 patients received long-acting SSA up to 21 days prior to PET/CT examination and 37 patients without pre-treatment with SSAs. Maximum and mean standardized uptake values (SUV max and SUV mean ) of tumours and metastases (liver, lymphnode, mesenteric/peritoneal and bones) as well as representative background tissues (liver, spleen, adrenal gland, blood pool, small intestine, lung, bone) were measured, standard uptake value ratios (SUVR) between tumours/metastases and liver, likewise between tumours/metastases and corresponding specific background were calculated and compared between the two groups. Ergebnisse/Results SUV mean of liver (5.36±1.51 vs. 6.77±1.85) and spleen (17.40±6.85 vs. 36.69±10.30) were significantly lower (p<0.001) and SUV mean of blood pool (1.69±0.56 vs. 1.27±0.35) was significantly higher (p<0.001) in patients with SSA pre-treatment compared to patients without. No significant differences between tumour-to-liver and specific tumour-to-background SUVRs were observed between both groups (all p>0.05). Schlussfolgerungen/Conclusions In patients previously treated with SSAs, a significantly lower SSTR expression ( 18 F-SiTATE uptake) in normal liver and spleen tissue was observed, as previously reported for 68 Ga-labelled SSAs, without significant reduction of tumour-to-background contrast. Therefore, there is no evidence that SSA treatment needs to be paused prior to 18 F-SiTATE-PET/CT. Publication History Article published online: 14 April 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.313
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueNuklearmedizin - NuclearMedicineSame topicNeuroendocrine Tumor Research AdvancesFrench-language works237,207